news-med.jpg

Henning Steinhagen appointed as Executive Vice President Drug Discovery and Development and Site-Head Verona

We are pleased to announce the appointment of Henning Steinhagen, PhD, as Executive Vice President Drug Discovery and Development, and Site-Head Verona, completing Aptuit’s executive leadership team.

Topics: New appointments Read More

Aptuit obtains renewal of French CIR tax accreditation

Good news for our French customers! We have renewed our French CIR tax accreditation for 2016-2018. So you will continue to benefit from 20-30% tax relief when you use our services. “The renewal of the CIR accreditation for an additional three-year period will provide additional tangible benefits ...

Topics: Finance Read More

Aptuit announces acquisition of Kuecept Ltd

Expanding capabilities in formulation development to include specialist pre-formulation, formulation prototyping and formulation development services Greenwich, CT, May, 10th, 2016 - Aptuit, LLC today announced that it has acquired Kuecept Ltd to meet strong customer demand for specialist drug ...

Topics: Business, Acquisition Read More

Iain Rusling, Appointed VP of Quality Management and EHS

We are pleased to announce the appointment of Iain Rusling as Vice President of Quality Management and EHS. Iain joins us directly from Sandoz, where he was Head of Third Party QA, Europe/META. In this role he led all quality aspects for over 350 third party contract manufacturers in Western Europe ...

Topics: New appointments Read More

Aptuit announces acquisition of Exquiron Biotech AG

Expands Capabilities in Discovery to Include High Throughput Screening and Other Early Discovery Services Greenwich, CT, April 21st, 2016 - Aptuit, LLC today announced that it has acquired Exquiron Biotech AG to meet customer demand for fully integrated outsourced discovery services. Exquiron is a ...

Topics: Strategy, Business, Acquisition Read More

Vince Russell, Appointed Respiratory Discovery Director

We are very happy to announce the appointment of Vince Russell as Respiratory Discovery Director at Aptuit. Vince joins us with more than 26 years of experience in pharma, biotech and CRO drug discovery in the respiratory disease area. Most recently Vince spent six years as part of Argenta's senior ...

Topics: New appointments Read More

Aptuit and Icagen agree to strategic alliance

Alliance to Provide Drug Discovery Customers Access to Industry Leading Ion Channel and Transporter Technologies Greenwich, CT, February 22nd, 2016 - Aptuit LLC and Icagen, Inc. today announced a strategic alliance to give drug discovery customers access to ion channel and transporter technologies ...

Topics: Strategy, Business Read More

Mario Maio, Appointed Global Head of CMC

We are very happy to announce the appointment of Mario Maio as Global Head of CMC at Aptuit. Mario joins us after many years of R&D, and management & strategic experience in large pharmaceutical companies such as Roche, Merck, and Janssen. His career to date has seen him spend time in Italy, ...

Topics: New appointments Read More

Appointment of Aptuit as a member of EU-NETVAL

We are very pleased to announce that Aptuit has been included into the select network of EU-NETVAL (European Union Network of Laboratories for the Validation of Alternative Methods) laboratories. Acceptance to EU-NETVAL is restricted to laboratories experienced in advanced in vitro procedures, and ...

Topics: Business, Regulatory Read More

Aptuit announces 16M$ investment in capacity and capability

Significant increase in headcount, new capabilities in discovery and incremental increase in capacity in CMC Greenwich, CT, December 7th, 2015 -  Aptuit LLC announced it has commenced a growth program for 2016 to meet significant increase in demand from our customers in discovery, Chemistry, ...

Topics: Strategy, Business, Investments Read More